home > drugs a-z list > combipatch (estradiol, norethindrone acetate transdermal system) drug center

CombiPatch

font size

CombiPatch Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

CombiPatch Prescribing Information: Indications & Dosage

In women with an intact uterus, CombiPatch (estradiol, norethindrone acetate transdermal system) (estradiol/NETA transdermal system) is indicated for the following:

· Treatment of moderate to severe vasomotor symptoms associated with the menopause

· Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.

Read the complete drug monograph for CombiPatch »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

CombiPatch Patient Information: Side Effects

Treatment with estrogens long-term may increase the risk of heart attack, stroke, breast cancer, and blood clots in the lungs or legs. Because of these risks, you should contact your doctor or healthcare provider to discuss your individual risks and benefits before using estradiol and norethindrone long-term. You should also talk to your doctor or healthcare provider on a regular basis (for example, every 3-6 months) about whether you should continue this treatment.

If you experience any of the following serious side effects, stop using estradiol and norethindrone and seek emergency...

Read the complete patient information for CombiPatch »

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

CombiPatch Consumer Information: Uses

This medication contains 2 female hormones: an estrogen (estradiol) and a progestin (norethindrone). It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. The progestin in this medication helps to reduce the risk of cancer of the uterus which can be caused by using estrogen. Women who have had their uterus removed do not need the progestin and therefore should not use this combination medication. This medication may also be used by women who are not able to produce enough estrogen (for exampl...

Read the complete consumer information for CombiPatch »

What is CombiPatch Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

CombiPatch - User Reviews

CombiPatch User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication CombiPatch sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.